Biovac's R2bn plan for vaccine production and export
25 July 2021 - 05:15
The Cape Town company that has signed with Pfizer and BioNTech to produce their Covid vaccine for distribution in Africa is planning a new €130m (about R2bn) facility that could produce up to 500-million doses a year by 2026, and is in talks with development finance institutions (DFIs) to fund this...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
There’s never been a more important time to support independent media.
From World War 1 to present-day cosmopolitan South Africa and beyond, the Sunday Times has been a pillar in covering the stories that matter to you.
For just R80 you can become a premium member (digital access) and support a publication that has played an important political and social role in South Africa for over a century of Sundays. You can cancel anytime.
Already subscribed? Sign in below.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.